NUVA - NuVasive, Inc.
| Previous Close | 57.92 |
| Open | 58.01 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's Range | 57.09 - 58.01 |
| 52 Week Range | 43.51 - 72.41 |
| Volume | 240,340 |
| Avg. Volume | 404,306 |
| Market Cap | 2.986B |
| Beta (3Y Monthly) | 1.34 |
| PE Ratio (TTM) | 61.67 |
| EPS (TTM) | 0.93 |
| Earnings Date | Jul 29, 2019 - Aug 2, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.67 |
- PR Newswire•16 hours ago
NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion
SAN DIEGO, June 17, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-O, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This further expands the application of the Company's Advanced Materials Science™ (AMS) portfolio to more of its procedural offerings and the most commonly performed procedure in the spine industry. Modulus TLIF-O features porous surface technology that, based on pre-clinical data, provides a favorable environment for bone in-growth and bone on-growth, and consistently achieves stronger osseointegration than solid implants with smooth or rough surfaces.1-4 The porous and roughened endplate design promotes new bone on-growth at four weeks and demonstrates the greatest integration strength by 12 weeks compared to alternative implant materials.5 Modulus TLIF-O's lattice structure is optimized for each implant size through NuVasive's proprietary algorithm that balances strength and radiolucency, while also mimicking the stiffness of bone.5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.
- PR Newswire•6 days ago
NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards
SAN DIEGO, June 12, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the Radiological, Imaging and Electromechanical Devices category at the 2019 Medical Design Excellence Awards (MDEA) held in New York City on June 11, 2019. The LessRay platform is built on a proprietary algorithm that captures and enhances low-dose, low-quality images to produce images with similar diagnostic capabilities as conventional full-dose images. This technology has the ability to reduce radiation emissions to the operating room (OR) staff and patient by 75 percent compared to standard fluoroscopy.1 Additionally, LessRay contains a number of surgical efficiency features designed to save time during spine surgery, which can decrease time under anesthesia for the patient.
- Markit•8 days ago
See what the IHS Markit Score report has to say about NuVasive Inc.
NuVasive Inc NASDAQ/NGS:NUVAView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for NUVA with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on May 28. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $118 million over the last one-month into ETFs that hold NUVA are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•18 days ago
Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report?
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire•19 days ago
NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System
SAN DIEGO, May 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions announced today that the Company's SpineTRACK Registry submitted successful quality performance data to the Centers of Medicare & Medicaid Services (CMS) on behalf of healthcare providers at Southern Oregon Neurosurgical & Spine Associates (SONSA) for the Merit-based Incentive Payment System (MIPS). As a result, SONSA providers are eligible for a positive adjustment of up to seven percent on all Medicare reimbursements for the 2020 payment year.
- Simply Wall St.•20 days ago
Is NuVasive, Inc. (NASDAQ:NUVA) A Financially Sound Company?
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as NuVasive, Inc...
- Thomson Reuters StreetEvents•21 days ago
Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT
Q1 2019 NuVasive Inc Earnings Call
- Zacks•21 days ago
Here's Why You Should Retain NuVasive (NUVA) Stock for Now
Investor confidence in the stock is high on NuVasive's (NUVA) sturdy spine business.
- Zacks•last month
VREX vs. NUVA: Which Stock Is the Better Value Option?
VREX vs. NUVA: Which Stock Is the Better Value Option?
- PR Newswire•last month
NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its commitment to the Society of Lateral Access Surgery (SOLAS) as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida. NuVasive will also participate in exhibit and workshop programs, featuring its comprehensive approach to lateral single-position surgery with the X360™ system integrated with Surgical Intelligence™. During the meeting, NuVasive will host a lunch symposia, X360 powered by Surgical Intelligence, presented by Brett Braly, MD, and Brian Kwon, MD, on May 17, 2019 from 12:45 to 2:15 p.m. ET.
- PR Newswire•last month
NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.
- Simply Wall St.•last month
How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching NuVasive, Inc. (NASDAQ:NUVA) might want to consider the historical volatility of t...
- Zacks•2 months ago
NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong
NuVasive's (NUVA) solid international sales in Q1 boost investor confidence in the stock.
Motley Fool•2 months agoNuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript
NUVA earnings call for the period ending March 31, 2019.
- Motley Fool•2 months ago
NuVasive Straightens Up to Start 2019
The spinal-surgery specialist gave investors solid performance.
- Zacks•2 months ago
NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates
NuVasive (NUVA) delivered earnings and revenue surprises of 29.27% and 2.21%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
NuVasive: 1Q Earnings Snapshot
The San Diego-based company said it had net income of 18 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to 53 cents per share. The results surpassed Wall Street ...
- PR Newswire•2 months ago
NuVasive Announces First Quarter 2019 Financial Results
SAN DIEGO , May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...
- Benzinga•2 months ago
A Preview Of NuVasive's Q1 Earnings
On Wednesday, May 1, NuVasive (NASDAQ: NUVA ) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Earnings and Revenue NuVasive earnings will be near 41 ...
- Insider Monkey•2 months ago
Is NuVasive, Inc. (NUVA) A Good Stock To Buy?
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon and Netflix ranked among the top 30 picks and both lost more than 25%. Facebook, which was the second most popular stock, lost 20% amid uncertainty regarding the interest rates and tech […]
- Zacks•2 months ago
NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth
NuVasive (NUVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
